查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1710158

2025年大腸癌篩檢全球市場報告

Colorectal Cancer Screening Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年結直腸癌篩檢市場規模將強勁成長。到 2029 年，這一數字將成長至 210.1 億美元，複合年成長率為 6.1%。預測期內的成長可歸因於向非侵入性篩檢方法的轉變、家庭篩檢測試的增加、肥胖盛行率的上升、基於價值的醫療保健的採用率的提高以及官民合作關係關係的增加。預測期內的關鍵趨勢包括人工智慧在篩檢和診斷中的整合、篩檢指南向年輕人群的擴展、廣泛使用基因組檢測來檢測癌症風險、行動醫療(行動醫療) 平台的成長以及製藥和診斷公司之間的合作。

預計未來幾年老齡人口的增加將推動大腸癌篩檢市場的成長。老化是指人口結構的一種趨勢，其特徵是勞動年齡人口中老年人口（一般為 65 歲及以上）的比例不斷增加，這通常是由於預期壽命延長和出生率下降造成的。隨著預期壽命的增加和出生率的下降，世界人口中老年人的比例不斷增加。大腸直腸癌篩檢透過早期發現和採取預防措施，在滿足日益成長的老年人口的需求方面發揮關鍵作用。這對於解決老年人日益增加的癌症風險和改善他們的整體健康狀況至關重要。例如，根據美國非營利研究機構人口研究委員會（PRB）2024年1月的資料，預計美國65歲及以上人口數量將從2022年的5800萬成長到2050年的8200萬，增幅為47%。此外，老年人口在總人口中所佔比例預計將從17%上升至23%。因此，老齡人口的增加是大腸直腸癌篩檢市場的主要驅動力。

大腸直腸癌篩檢市場的關鍵參與企業正專注於開發創新解決方案，例如非侵入性、多靶點糞便核糖核酸 (RNA) 結直腸癌篩檢測試，以提供可行且有效的早期檢測方法，改善患者預後並鼓勵更廣泛地參與篩檢。非侵入性多標靶糞便RNA結直腸癌篩檢檢測可透過評估糞便檢體中的RNA標記來識別結直腸癌和癌前病變的存在，為早期檢測提供非手術方法。例如，2024年5月，美國生命科學公司Geneoscopy Inc.宣布其ColoSense已獲得美國食品藥物管理局（FDA）的核准。該測試是一種非侵入性的、基於糞便的篩檢方法，使用 RNA 生物標記物，對檢測大腸直腸癌的敏感性為 93%，對檢測晚期腺瘤的敏感性為 45%。該測試的意義在於它的高準確性，特別是對於年輕人而言，並且透過提供一種比傳統測試方法更微創的替代方法，有可能提高篩檢率。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球大腸直腸癌篩檢PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球大腸直腸癌篩檢市場：成長率分析
  • 全球大腸直腸癌篩檢市場表現：規模與成長，2019-2024
  • 全球大腸癌篩檢市場預測：規模與成長，2024-2029 年，2034 年
  • 全球大腸直腸癌篩檢總目標市場（TAM）

第6章市場區隔

  • 全球大腸直腸癌篩檢市場類型、表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 根據航班
  • 大便潛血試驗（FIT）
  • 大便潛血試驗（FOBT）
  • 糞便去氧核糖核酸（DNA）檢測
  • 大腸鏡檢查
  • 其他類型
  • 全球大腸直腸癌篩檢市場：依年齡層、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 50歲以下
  • 50-64歲
  • 65歲或以上
  • 全球大腸癌篩檢市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 臨床實驗室
  • 診斷影像中心
  • 其他最終用戶
  • 全球大腸癌篩檢市場，依糞便檢驗類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 糞便檢驗
  • 全球大腸直腸癌篩檢市場按大便潛血試驗(FIT) 類型細分、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 高靈敏度FIT
  • 低靈敏度 FIT
  • 全球大腸直腸癌篩檢市場按大便潛血試驗(FOBT) 類型細分、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 癒創木脂糞便潛血試驗
  • 免疫化學糞便潛血試驗
  • 全球大腸直腸癌去氧核糖核酸市場依糞便 DNA 檢測類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 多目標糞便DNA檢測
  • 單目標糞便DNA檢測
  • 全球大腸癌篩檢市場，依大腸鏡檢查類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 診斷性大腸鏡檢查
  • 治療性大腸鏡檢查
  • 全球大腸癌篩檢市場及其他細分市場，依類型、實際規模及預測，2019-2024 年、2024-2029 年、2034 年
  • 虛擬大腸鏡檢查
  • 軟性乙狀結腸鏡檢查
  • 膠囊內視鏡檢查

第7章 區域和國家分析

  • 全球大腸癌篩檢市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球大腸癌篩檢市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 大腸直腸癌篩檢市場：競爭格局
  • 大腸直腸癌篩檢市場：公司簡介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Boston Scientific Corporation
  • Olympus Corporation
  • Hologic Inc.
  • bioMerieux SA
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • QIAGEN NV
  • Exact Sciences Corporation
  • Guardant Health Inc.
  • Eiken Chemical Co. Ltd.
  • HemoCue AB
  • Clinical Genomics Inc.
  • Polymedco LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年大腸癌篩檢市場：提供新機會的國家
  • 2029年大腸癌篩檢市場：細分領域帶來新機會
  • 2029年大腸直腸癌篩檢市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r31737

Colorectal cancer screening refers to testing procedures aimed at detecting early signs of colorectal cancer before symptoms manifest. Early detection through screening can identify precancerous polyps or cancer at a more treatable stage, significantly enhancing patient outcomes. Screening is recommended for adults starting at age 45, or earlier for those at higher risk.

The primary types of colorectal cancer screening include stool-based tests, fecal immunochemical tests (FIT), fecal occult blood tests (FOBT), stool deoxyribonucleic acid (DNA) tests, and colonoscopy, among others. Stool-based colorectal cancer screening involves analyzing a stool sample for indicators of cancer-related substances or abnormalities, such as blood or DNA mutations, to identify potential colorectal cancer. These screenings are categorized by age groups, including individuals under 50, those aged 50-64, and those over 65. The end users of these tests encompass hospitals and clinics, clinical laboratories, diagnostic imaging centers, and other healthcare providers.

The colorectal cancer screening market research report is one of a series of new reports from The Business Research Company that provides colorectal cancer screening market statistics, including colorectal cancer screening industry global market size, regional shares, competitors with a colorectal cancer screening market share, detailed colorectal cancer screening market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer screening industry. This colorectal cancer screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The colorectal cancer screening market size has grown strongly in recent years. It will grow from $15.61 billion in 2024 to $16.6 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to the increasing incidence of colorectal cancer, rising government awareness campaigns, an aging population, growing adoption of colonoscopy, and improved insurance coverage.

The colorectal cancer screening market size is expected to see strong growth in the next few years. It will grow to $21.01 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to a shift to non-invasive screening methods, increasing home-based screening tests, growing prevalence of obesity, rising adoption of value-based healthcare, and increasing public-private partnerships. Major trends in the forecast period include the integration of AI in screening and diagnostics, expansion of screening guidelines to younger populations, broader use of genomic testing for cancer risk, growth in mobile health (mHealth) platforms, and collaborations between pharmaceutical and diagnostic companies.

The increasing aging population is projected to drive the growth of the colorectal cancer screening market in the coming years. An aging population refers to a demographic trend characterized by a rising proportion of elderly individuals (typically those aged 65 and older) relative to the working-age population, often resulting from longer life expectancies and declining birth rates. As life expectancies increase and birth rates decline, the share of older adults in the global population continues to grow. Colorectal cancer screening plays a crucial role in addressing the needs of this expanding aging population by enabling early detection and preventive measures, which are essential for managing the heightened cancer risk among older adults and improving their overall health outcomes. For example, in January 2024, data from the Population Reference Bureau (PRB), a U.S.-based nonprofit research organization, projected that the number of Americans aged 65 and older would rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, their share of the total population is expected to grow from 17% to 23%. Thus, the increasing aging population is a significant driver of the colorectal cancer screening market.

Key players in the colorectal cancer screening market are focusing on developing innovative solutions, such as non-invasive multi-target stool ribonucleic acid (RNA) colorectal cancer screening tests, to provide accessible and effective early detection methods, thereby improving patient outcomes and promoting wider screening participation. Non-invasive multi-target stool RNA colorectal cancer screening tests evaluate RNA markers from stool samples to identify the presence of colorectal cancer or precancerous lesions, offering a non-surgical approach for early detection. For instance, in May 2024, Geneoscopy Inc., a U.S.-based life sciences company, announced that it received U.S. Food and Drug Administration (FDA) approval for ColoSense. This test utilizes RNA biomarkers for a non-invasive, stool-based screening method that demonstrated 93% sensitivity in detecting colorectal cancer and 45% sensitivity for advanced adenomas. Its significance lies in its high accuracy, particularly among younger populations, and its potential to enhance screening rates by providing a less invasive alternative to traditional methods.

In November 2023, Geneoscopy Inc. partnered with Laboratory Corporation (LabCorp), a U.S.-based life science and healthcare company, to broaden access to Geneoscopy's non-invasive multi-target stool RNA colorectal cancer screening test. This collaboration aims to improve early and sensitive detection of colorectal cancer and precancerous lesions, address health disparities, and increase screening rates by leveraging LabCorp's extensive network of healthcare providers and patients. LabCorp is known for offering colon cancer screening and diagnostic tests.

Major companies operating in the colorectal cancer screening market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, FUJIFILM Holdings Corporation, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC, Hemosure Inc., Geneoscopy Inc., Novigenix SA

North America was the largest region in the colorectal cancer screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the colorectal cancer screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The colorectal cancer screening market includes revenues earned by entities by providing services such as genetic and molecular testing, patient education and awareness programs, and screening result analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Colorectal Cancer Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on colorectal cancer screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for colorectal cancer screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The colorectal cancer screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Stool-Based; Fecal Immunochemical Test (FIT); Fecal Occult Blood Test (FOBT); Stool Deoxyribonucleic Acid (DNA) Test; Colonoscopy; Other Types
  • 2) By Age Group: Below 50 Years; 50-64 Years; Above 65 Years
  • 3) By End User: Hospitals And Clinics; Clinical Laboratories; Diagnostic Imaging Centers; Other End-Users
  • Subsegments:
  • 1) By Stool-Based Tests: Stool-Based Tests
  • 2) By Fecal Immunochemical Test (FIT): High-Sensitivity FIT; Low-Sensitivity FIT
  • 3) By Fecal Occult Blood Test (FOBT): Guaiac FOBT; Immunochemical FOBT
  • 4) By Stool Deoxyribonucleic Acid (DNA) Test: Multi-Target Stool DNA Test; Single-Target Stool DNA Test
  • 5) By Colonoscopy: Diagnostic Colonoscopy; Therapeutic Colonoscopy
  • 6) By Other Types: Virtual Colonoscopy; Flexible Sigmoidoscopy; Capsule Endoscopy
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Medtronic plc; Siemens Healthineers
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Colorectal Cancer Screening Market Characteristics

3. Colorectal Cancer Screening Market Trends And Strategies

4. Colorectal Cancer Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Colorectal Cancer Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Colorectal Cancer Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Colorectal Cancer Screening Market Growth Rate Analysis
  • 5.4. Global Colorectal Cancer Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Colorectal Cancer Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Colorectal Cancer Screening Total Addressable Market (TAM)

6. Colorectal Cancer Screening Market Segmentation

  • 6.1. Global Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stool-Based
  • Fecal Immunochemical Test (FIT)
  • Fecal Occult Blood Test (FOBT)
  • Stool Deoxyribonucleic Acid (DNA) Test
  • Colonoscopy
  • Other Types
  • 6.2. Global Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Below 50 Years
  • 50-64 Years
  • Above 65 Years
  • 6.3. Global Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Clinical Laboratories
  • Diagnostic Imaging Centers
  • Other End-Users
  • 6.4. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Stool-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stool-Based Tests
  • 6.5. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Fecal Immunochemical Test (FIT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Sensitivity FIT
  • Low-Sensitivity FIT
  • 6.6. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Fecal Occult Blood Test (FOBT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Guaiac FOBT
  • Immunochemical FOBT
  • 6.7. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Stool Deoxyribonucleic Acid (DNA) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Multi-Target Stool DNA Test
  • Single-Target Stool DNA Test
  • 6.8. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Colonoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Colonoscopy
  • Therapeutic Colonoscopy
  • 6.9. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Virtual Colonoscopy
  • Flexible Sigmoidoscopy
  • Capsule Endoscopy

7. Colorectal Cancer Screening Market Regional And Country Analysis

  • 7.1. Global Colorectal Cancer Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Colorectal Cancer Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Colorectal Cancer Screening Market

  • 8.1. Asia-Pacific Colorectal Cancer Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Colorectal Cancer Screening Market

  • 9.1. China Colorectal Cancer Screening Market Overview
  • 9.2. China Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Colorectal Cancer Screening Market

  • 10.1. India Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Colorectal Cancer Screening Market

  • 11.1. Japan Colorectal Cancer Screening Market Overview
  • 11.2. Japan Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Colorectal Cancer Screening Market

  • 12.1. Australia Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Colorectal Cancer Screening Market

  • 13.1. Indonesia Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Colorectal Cancer Screening Market

  • 14.1. South Korea Colorectal Cancer Screening Market Overview
  • 14.2. South Korea Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Colorectal Cancer Screening Market

  • 15.1. Western Europe Colorectal Cancer Screening Market Overview
  • 15.2. Western Europe Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Colorectal Cancer Screening Market

  • 16.1. UK Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Colorectal Cancer Screening Market

  • 17.1. Germany Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Colorectal Cancer Screening Market

  • 18.1. France Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Colorectal Cancer Screening Market

  • 19.1. Italy Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Colorectal Cancer Screening Market

  • 20.1. Spain Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Colorectal Cancer Screening Market

  • 21.1. Eastern Europe Colorectal Cancer Screening Market Overview
  • 21.2. Eastern Europe Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Colorectal Cancer Screening Market

  • 22.1. Russia Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Colorectal Cancer Screening Market

  • 23.1. North America Colorectal Cancer Screening Market Overview
  • 23.2. North America Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Colorectal Cancer Screening Market

  • 24.1. USA Colorectal Cancer Screening Market Overview
  • 24.2. USA Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Colorectal Cancer Screening Market

  • 25.1. Canada Colorectal Cancer Screening Market Overview
  • 25.2. Canada Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Colorectal Cancer Screening Market

  • 26.1. South America Colorectal Cancer Screening Market Overview
  • 26.2. South America Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Colorectal Cancer Screening Market

  • 27.1. Brazil Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Colorectal Cancer Screening Market

  • 28.1. Middle East Colorectal Cancer Screening Market Overview
  • 28.2. Middle East Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Colorectal Cancer Screening Market

  • 29.1. Africa Colorectal Cancer Screening Market Overview
  • 29.2. Africa Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Colorectal Cancer Screening Market Competitive Landscape And Company Profiles

  • 30.1. Colorectal Cancer Screening Market Competitive Landscape
  • 30.2. Colorectal Cancer Screening Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Colorectal Cancer Screening Market Other Major And Innovative Companies

  • 31.1. FUJIFILM Holdings Corporation
  • 31.2. GE HealthCare
  • 31.3. Boston Scientific Corporation
  • 31.4. Olympus Corporation
  • 31.5. Hologic Inc.
  • 31.6. bioMerieux SA
  • 31.7. QuidelOrtho Corporation
  • 31.8. Sysmex Corporation
  • 31.9. QIAGEN N.V.
  • 31.10. Exact Sciences Corporation
  • 31.11. Guardant Health Inc.
  • 31.12. Eiken Chemical Co. Ltd.
  • 31.13. HemoCue AB
  • 31.14. Clinical Genomics Inc.
  • 31.15. Polymedco LLC

32. Global Colorectal Cancer Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Colorectal Cancer Screening Market

34. Recent Developments In The Colorectal Cancer Screening Market

35. Colorectal Cancer Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Colorectal Cancer Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Colorectal Cancer Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Colorectal Cancer Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer